Published in Magn Reson Med on May 01, 1991
MR-visible lipids and the tumor microenvironment. NMR Biomed (2011) 1.13
In vivo 1D and 2D correlation MR spectroscopy of the soleus muscle at 7T. J Magn Reson (2010) 0.80
Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93
Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60
Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38
Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35
Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24
Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23
Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis (2009) 1.22
Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15
Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13
Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology (1997) 1.13
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10
Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. Trends Biochem Sci (1988) 1.08
Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06
Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05
Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04
Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02
Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02
Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02
Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med (1994) 0.95
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94
A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94
Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93
Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93
Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91
Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91
Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90
Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90
A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90
Biliary sepsis. Reviewing treatment options. Drugs (1986) 0.90
Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J Biol Chem (1986) 0.89
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89
Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts. Int J Cancer (1988) 0.89
Bacterial metabolism of human polymorphonuclear leukocyte-derived arachidonic acid. Infect Immun (1992) 0.88
Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry (1992) 0.88
Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci (2009) 0.88
Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology. Magn Reson Med (1993) 0.87
Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. Eur J Biochem (1992) 0.87
Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient. Nephrol Dial Transplant (1991) 0.86
Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann N Y Acad Sci (1994) 0.86
Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives. Infect Immun (1991) 0.86
Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report. Clin Infect Dis (1994) 0.85
Infection of vascular prostheses. Aust N Z J Surg (1991) 0.85
Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. Eur J Clin Microbiol Infect Dis (2008) 0.85
Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab (1995) 0.85
A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol (2000) 0.85
Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods. Biochemistry (1984) 0.84
Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World J Surg (1996) 0.84
Application of a T2-filtered COSY experiment to identify the origin of slowly relaxing species in normal and malignant tissue. Magn Reson Med (1988) 0.84
Regulatory roles for the homeodomain and C2H2 zinc finger regions of Cryptococcus neoformans Ste12alphap. Mol Microbiol (2004) 0.83
Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int J Cancer (1996) 0.82
Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms. World J Surg (1995) 0.82
Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells. Magn Reson Med (1991) 0.82
Classification of human tumours by high-resolution magnetic resonance spectroscopy. Lancet (1986) 0.82
Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J (2014) 0.81
Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun (1997) 0.81
Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer? Pathology (2015) 0.81
Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy. Int J Cancer (1994) 0.81
Effect of pyocyanin and 1-hydroxyphenazine on the assay of lactate dehydrogenase activity. J Infect Dis (1991) 0.81
Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis. Clin Exp Immunol (1994) 0.81
Exogenous ocular candidiasis associated with intravenous heroin abuse. Br J Ophthalmol (1984) 0.81
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis (2006) 0.81
Phospholipid and ether linked phospholipid content alter with cellular resistance to vinblastine. Biochem Biophys Res Commun (1985) 0.81
Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology (1993) 0.81
Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer. NMR Biomed (1988) 0.80
Neurological toxicity associated with vidarabine (adenine arabinoside) therapy. Aust N Z J Med (1983) 0.80
Proton magnetic resonance and human thyroid neoplasia III. Ex vivo chemical-shift microimaging. J Magn Reson B (1996) 0.80
Pneumonia with bacteraemia due to Escherichia coli. Aust N Z J Med (1981) 0.80
Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line. Int J Cancer (1996) 0.80
GMP-140 (P-selectin) inhibits human neutrophil activation by lipopolysaccharide: analysis by proton magnetic resonance spectroscopy. Biochem Biophys Res Commun (1992) 0.80
Divergent expression of cytotoxic and microbicidal functions of rabbit alveolar and peritoneal macrophages: effects of non-specific activation and a natural microbicidal peptide, MCP-1. Aust J Exp Biol Med Sci (1985) 0.79
Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA). Med Mycol (2005) 0.79
Antimicrobial therapy of postpartum endomyometritis. I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria. Am J Obstet Gynecol (1981) 0.79
Further evidence that the narrow 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets. NMR Biomed (1989) 0.79